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HIV Mission
CDC's HIV mission is to prevent 
HIV infection and reduce the 
incidence of HIV-related illness 
and death, in collaboration with 
community, state, national, and 
international partners.
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CDC HIV Prevention Functions
(by Centers, Institutes, and Offices)
HIV Organization
Director, CDC I Health Communications
Deputy Director 1 and Social Marketing 
Hotline
Clearinghouse 
Minority Outreach 
National Private Sector 
Initiatives 
Communications
Associate Director for I
HIV/AIDS |
Research
National Center for
infectious Diseases
National Center for 
Prevention Services
National Center for 
Chronic Disease 
Prevention and 
Health Promotion
------------------------------------
National Institute 
for Occupational 
Safety and Health
Surveillance 
Epidemiology 
Laboratory Science 
Health-Care Workers
State and Local HIV 
Prevention 
Risk Reduction 
Health Education 
Minority Outreach 
TB Control
School Health 
Education
Reproductive Health 
Minority Outreach 
Behavioral 
Surveillance
HIV in the Work Place 
Personal Protective 
Equipment 
Control Technology 
Health Hazards
Public Health 
Practice 
Program Office
International Health 
Program Office
National Center for 
Health Statistics
Epidemiology 
Program Office
National Center for 
Environmental 
Health
Laboratory 
Performance 
Evaluation 
Laboratory Training
Liaison with National 
and International 
Agencies
Long- and Short-Term 
International Technical 
Assistance
General Population 
Surveys 
Vital Statistics
EIS Program 
MMWR Series
Laboratory Technical 
Support
C D c m m m«NT£RS fOft Ea&fASC CtWTIWX P*tVt»'«X PREVENTION
2 1994 Fact Book
HIV Prevention M ilestones
CDC provides training 
to laboratory staff to 
perform new test for 
antibodies
CDC publishes 
first infection 
control precautions 
for clinical and 
laboratory staffs
I
AIDS case
surveillance
begins
U.S. Conference of Mayors 
receives CDC support for 
community HIV prevention 
projects
Projet SIDA 
begins in
Kinshasa, c d c  organizes first International 
^ aire _  AIDS Conference in Atlanta
CDC publishes universal 
precautions for prevention 
of bloodborne infections 
in health-care workers
National HIV sero- 
surveillance begins 
■
The CDC National AIDS 
Clearinghouse begins 
operation
"America Responds to 
AIDS" public information 
campaign launched
First 
national 
case con­
trol study 
published 
clearly 
implicating 
a sexually 
transmitted 
infection 
as the 
cause 
of AIDS
CDC's MMWR 
publishes first 
report of AIDS 
in adults
1981 1982 1983 1984 1985
CDC publishes recommendations 
for preventing transmission of HIV 
infection in the workplace 
■
CDC provides financial and technical 
assistance to state and local health 
departments to establish alternate 
counseling and testing sites to protect 
the nation's blood supply
CDC revises AIDS 
surveillance case defin ition
CDC publishes recommen­
dations for preventing 
perinatal transmission 
of the AIDS virus
CDC provides financial 
and technical assistance 
to state and local educa­
tion agencies for preven­
tion of HIV infection
■
CDC provides funds 
to national organiza­
tions serving youth
CDC revises AIDS 
surveillance case 
definition
1986 1987
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CDC initiates an extensive 
external review of its 
major HIV program areas
CDC reports 
first HIV-2 
infection in U.S.
CDC begins direct 
funding of minority 
and other community- 
based organizations
CDC begins direct 
funding of national 
and regional minority 
organizations
"Understanding AIDS" 
brochure mailed to 
to every U.S. 
household
■
CDC publishes guide­
lines for school health 
education programs
CDC develops partner­
ships with national and 
regional organizations, 
business and industry, 
and religious organizations
CDC publishes recom­
mendations to prevent 
HIV transmission to 
patients during exposure- 
prone invasive procedures
CDC issues HIV Prevention Community 
Planning guidance for State and local 
health department grantees to ensure 
greater com m unity involvement in 
determining HIV prevention needs 
and developing responsive 
programs
■
CDC launches an HIV Prevention 
Marketing Initiative to prevent 
sexual transmission of HIV among 
young people 18-25 years of age 
■
CDC develops new strategic plan for 
international HIV engagement
CDC publishes guidelines 
for prophylaxis against PCP 
for HIV-infected children
CDC provides financial 
and technical assistance 
to colleges and 
universities for HIV 
prevention activities
CDC publishes recommenda­
tions for prophylaxis/therapy 
for disseminated M. avium 
complex for HIV-infected 
adults/adolescents 
CDC pioneers use of 
PCR in epidemiologic 
investigation of HIV- 
infected persons
CDC rev isS he  HIV 
classification system and 
expands AIDS surveil­
lance case definition
CDC launcffSs "Business 
Responds to AIDS" Program
CDC publishes recom­
mendations for prophy­
laxis against PCP in 
HIV-inTected adults and 
adolescents
CDC and NIH publicize 
findings and issue 
recommendations 
regarding the efficacy 
of zidovudine 
in reducing 
perinatal transmission 
when given to HIV-infected 
pregnant women
CDC pub 
guidelines for 
preventing HIV 
transmission 
through 
transplantation 
of human tissue
1988 1989 1990 1991 1992 1993
and organs
1994
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HIV Budget
PHS HIV Budget 
Fiscal Year 1994
(in Millions of Dollars)
IHS $4 (0.1%)
CDC $543 (21
NIH $1301 (50.9%)
HRS A $608 (23.6%)
DA $72 (2.8%) 
OASH $5 (0.1%) 
AHCPR $11 (0.4%) 
AMHSA $28 (1.0%)
Total: $2,572
Agency for Health Care Policy and Research
Centers for Disease Control and Prevention
Pood and Drug Administration
Health Resources and Services Administration
Indian Health Service
National Institutes of Health
Office of the Assistant Secretary for Health
Substance Abuse and Mental Health Services Administration
CDCCENTOS FOR CNSEASC CONTROL HIV/AIDSPR E V EN T IO N 1994 Fact Book
HIV Budget
CDC HIV/AIDS Prevention 
Fiscal Year 1994 Appropriations 
By Major Budget Categories
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HIV Budget
CDC HIV Prevention Budget 
Fiscal Year 1994, Extramural Funding
Intramural
National public information activities 
Directly funded CBOs 
State and local education agencies 
National and regional organizations
Other (universities, hospitals, 
private organizations)
State and local health departments
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HIV/AIDS Trends
Annual AIDS Cases, by Year of Report 
United States, 1981 - 1993
Cases in 
Thousands
□ 1993
Expanded
Definition
P re-1993
* In 1993, the AIDS surveillance case definition for adolescents and adults was expanded beyond the definition published in 1987 
to include all HIV-infected persons with severe immunosuppression (<200 CD4+ T-lymphocytes/pL or a CD4+ T-lymphocyte 
percentage of total lymphocytes of <14), pulmonary tuberculosis, recurrent pneumonia, or invasive cervical cancer.
CD£
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Death Rates* for Leading Causes of Death 
Among Men 25-44 Years, by Year—
United States, 1982-1992+
HIV/AIDS Trends
HIV
Unintentional Injuries
Diseases of Heart
Malignant Neoplasms
Homicide
Suicide
Cerebrovascular Diseases 
Diabetes Mellitus 
Pneumonia & Influenza
Chronic Liver Disease/Cirrhosis
CDC
and mevtmoN
t
Per 100,000 population.
National vital statistics based on underlying cause of death, using final data for 1982-1991 
and provisional data for 1992. Data for liver disease in 1992 were unavailable.
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HIV/AIDS Trends
Death Rates* for Leading Causes of Death 
Among Women 25-44 Years, by Year—
United States, 1982-1992+
82 83 84 85 86 87 88 89 90 91 92
Year
Malignant Neoplasms
Unintentional Injuries 
■ ■
Diseases of Heart
HIV
Homicide
mm  ■
Suicide
Cerebrovascular Diseases
Diabetes Meilitus 
—^ —
Pneumonia & Influenza
■ i ■
Chronic Liver Disease/Cirrhosis
* Per 100,000 population.
t  National vital statistics based on underlying cause of death, using final data for 1982-1991 
and provisional data for 1992. Data for liver disease in 1992 were unavailable.
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hiv/ aids Trends
Cumulative U.S. AIDS Cases
Cumulative U.S. AIDS Cases
as of 7/89 N~100,000
CDC HIV/AIDSPR E V EN T IO N
Cum ulative U.S. AIDS Cases
as of 5/85 N~10,000
Cumulative U.S. AIDS Cases 
as of 12/93 N~360,000
10 Each point = 30 cases 1994 Fact Book
HIV/aids Trends
U.S. AIDS Cases Among Adults/Adolescents,
by Sex and Race/Ethnicity*, 
Reported through December 1993
□  Non-Hispanic White □  Non-Hispanic Black B  Hispanic
□  Asian/Pacific Islander ■  American Indian/Alaskan Native □  Unknown
‘ Race and ethnicity are not risk factors for HIV infection; an assessment of risk 
behavior is necessary to properly target prevention efforts.
HIV/AIDS
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HIV/AIDS Trends
AIDS Cases Among Adults and Adolescents, 
by Sex and Exposure Category, 
Reported Through December 1993
%
I I Men who have sex with men 
m  Injection drug use
S Men who have sex with men and inject drugs 
□  Hemophilia/coagulation disorder
EH Heterosexual contact
H  Receipt of blood transfusion, blood 
components, or tissue 
S  Risk not reported or identified
r r ^ r m w m m m
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HIV/AIDS Trends
AIDS Cases Among 
U.S. Children (<13 Years), 
Reported Through December 1993
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hiv/ aids Trends
U.S. HIV Infection Cases (Not AIDS) Reported in 1993 and 
Cumulatively Among Young People Aged 13-24 (From States 
with confidential HIV infection reporting*)
Cases 1993
1,600
1,400
1,200
1,000
800
600
400
200
0
13-19 20-24
Age
includes data from 25 States.
**States initiated HIV reporting in different 
years; cumulative case counts represent 
different time periods for each State.
_ Cumulative**
Cases
13-19 20-24
Age
H  Male 
□  Female
Source: HIV/AIDS Surveillance Report, July 1994
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1993 HIV Prevention Activities: Highlights
Reported AIDS Cases Among Adolescents and Adults 
First Quarter 1992 and 1993
40
1 st Quarter 1992 1 st Quarter 1993
I I 1993 Definition"{Adde<J opportunistic infections) 
f \ )  1993 Definition (Severe immunosuppression) 
H  Pre-1993 Definition
•All HIV-infected persons with severe immunosuppression (<200 CD4+ T-lymphocytes/pl or a CD4+ T-lymphocyte 
percentage of <14), pulmonary tuberculosis (TB), recurrent pneumonia, or invasive cervical cancer in addition to 
the clinical conditions included in the AIDS surveillance case definition published in 1987 
'•Pulmonary TB, recurrent pneumonia, and invasive cervical cancer.
Initiated an external review process for CDC's HIV prevention programs
and activities by individuals and groups outside of CDC who are experts in the 
field of HIV prevention. Five review groups were established by the CDC 
Advisory Committee on the Prevention of HIV Infection to examine CDC pro­
grams associated with (1) monitoring the HIV/AIDS epidemic; (2) promoting 
individuals’ knowledge of serostatus (counseling, testing, referral, and partner 
notification); (3) developing partnerships for HIV prevention; (4) preventing risk 
behaviors among school-aged populations; and (5) improving public under­
standing of the epidemic. The review groups presented their analyses, sug­
gested modifications, and proposed solutions to the Advisory Committee in 
November 1993; the Advisory Committee submitted a final report to CDC in 
May 1994.
Developed and distributed an HIV Prevention Community Planning Guid­
ance document, which outlines a process whereby the identification of high 
priority prevention needs is shared between health departments administer­
ing CDC funds and the communities for whom the services are intended. CDC 
held four meetings in which governmental and nongovernmental organiza­
tions provided extensive input on the need for open and candid participatory 
community planning. The HIV Prevention Community Planning process em­
braces the notion that the behavioral and social sciences must play a critical 
role in the development, implementation, and evaluation of HIV prevention 
programs within a given community. The guidance applies to all of CDC’s 
65 state, territorial, and local health department grantees.
Following publication of the expanded AIDS surveillance case definition and 
revised HIV classification system for adolescents and adults, conducted scien­
tific, programmatic, and operational activities to implement expanded 
case surveillance in the field and to assess the impact of the expansion. 
During 1993, more than 100,000 cases of AIDS were reported among adoles­
cents and adults, representing a more than 100 percent increase over the 
number of cases reported in 1992. Of the cases reported in 1993, more than 
half were reported based on the criteria added to the definition in 1993.
CDC
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1993 HIV Prevention Activities: Highlights
Launched an HIV Prevention Marketing initiative (PMI) to prevent the 
sexual transmission of HIV among young people. PMI represents the applica­
tion of marketing techniques and consumer-oriented health communica­
tions technologies based on science and is directed to the prevention of HIV 
and other sexually transmitted diseases (STDs) among young people 18-25 
years of age. PMI has four levels of activities:
1. A national component of communications focused on HIV prevention 
among young people in the 1990s, including the role of condoms in 
preventing sexual transmission of HIV.
2. Technology and information transfer to support development of 
effective HIV prevention activities.
3. Prevention marketing demonstration sites to expand the reach of the 
national program through involvement and coordination with five 
local sites in the development of HIV prevention programs.
4. integration of PMI with other CDC HIV prevention programs, particu­
larly the HIV Prevention Community Planning process.
A comprehensive research and evaluation plan is being implemented simul­
taneously with each component of the program, which will direct the plan­
ning and decision-making processes.
Published in the Morbidity and Mortality Weekly Report (MMWR) an
article discussing the science of condom efficacy, and specifically citing new 
studies that provide compelling evidence that latex condoms, when used 
consistently and correctly, are highly effective in preventing HIV transmis­
sion. Through PMI, CDC provided this article, along with supportive docu­
ments and materials, to state and local health departments for use in local 
HIV prevention and education activities.
HIV/AIDS
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1993 HIV Prevention Activities: Highlights
Percent of respondents who have talked with, received condoms, 
or received bleach from street outreach workers (OW) 
Baseline surveys, AIDS Evaluation of Street Outreach Projects
Have ever Have received Have received 
talked with OW condoms from OW bleach from OW
% % % N
IDU Sites
Chicago 17.3 16.3 13.6 417
Atlanta 63.3 57.9 44.5 428
LA County 44.9 39.8 51.3 403
Philadelphia 65.2 55.7 50.0 270
NY ADAPT 59.6 57.4 67.5 399
Youth Sites
LA Childrens 
Hospital
41.0 31.8 10.3 400
San Francisco 23.3 22.0 7.2 215
NY Victim 
Services
46.2 38.5 6.7 195
Completed data collection for the 1-year Youth Behavior Survey compo­
nent of the National Health Interview Survey, in which sensitive risk 
behavior data are collected from youth via portable audio tape recorders 
with headphones. The information is similar to that collected in the 
school-based Youth Risk Behavior Survey, but includes a wider range of 
ages as well as out-of-school youth.
Developed a new CDC-wide “Plan for Further Engagement in Interna­
tional HIV/AIDS Prevention and Control, 1994-1998." The primary goals 
of the plan are to (1) develop new assessment tools and prevention inter­
ventions, (2) develop and promote HIV prevention training, and (3) establish 
comprehensive HiV/STD Prevention Centers, including multidisciplinary 
program research, implementation, evaluation, and training. In addition, 
CDC has established an International HIV Committee to improve informa­
tion exchange, planning, and coordination of CDC’s international HIV activi­
ties.
Distributed the report of a CDC-sponsored review of needle exchange 
programs conducted by the University of California. In the report, 
entitled “The Public Health Impact of Needle Exchange Programs in the 
United States and Abroad," researchers concluded that (1) adequately 
funded needle exchange programs (NEPs) “have the potential to serve 
significant portions of the local injecting drug user population,” (2) “al­
though quantitative data are difficult to obtain, those available provide no 
evidence that [NEPs] increase the amount of drug use by needle exchange 
program clients" or increase drug use in the community, (3) most studies of 
NEP clients “demonstrate decreased rates of HIV drug risk behavior," and 
(4) multiple mathematical models of NEP impact “suggest that [NEPs] can 
prevent significant numbers of HIV infections among clients of the program, 
their drug and sex partners, and their offspring.”
HIV/ AIDS
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1993 HIV Prevention Activities: Highlights
CD4+ Cell Testing-Related Activities 
Public Health Practice Program Office
Expanded the Model Performance Evaluation Program (MPEP) activities 
to assess the performance quality of laboratories that perform CD4+ cell 
testing. This testing has become increasingly important in monitoring the 
immune status of patients infected with HIV and making decisions about 
initiation of antiretroviral therapy and opportunistic infection prophylaxis. 
Information collected from participating laboratories has provided valuable 
data on CD4+ cell testing practices which, when compared with performance 
evaluation testing, will assist CDC in understanding the quality of CD4+ cell 
testing in the United States and identifying factors that may affect such 
testing.
Played a pivotal role, through the Business Responds to AIDS (BRTA) 
program, in the stimulation and implementation of the President’s initia­
tive requiring that all Federal employees receive education about HIV 
infection and AIDS. The American Red Cross (ARC), a CDC grantee, has 
received more than 300 requests for training from Federal agencies for their 
work-place education programs. In addition, the BRTA Resource Service has 
received 494 calls from Federal agencies requesting assistance.
Enhanced tuberculosis (TB) surveillance systems to identify TB patients 
coinfected with HIV and ensure their appropriate therapy and case man­
agement; determine and monitor trends of TB cases with underlying HIV 
infection; describe epidemiologic and clinical characteristics of persons with 
TB disease and HIV infection-, and determine the prevalence of substance 
abuse among TB patients.
CDC HIV/ AIDS
Enrolled 240 women in the W omen’s AIDS Cohort Study, cofunded by the 
National Institutes of Health (NIH) and CDC, to evaluate the natural his­
tory of HIV disease in women. Of the 240 enrollees, 150 have had their 
first follow-up visit and 70 have had two follow-up visits. Preliminary find­
ings describe the prevalence of current and past sexually transmitted dis­
eases (STDs) and the association of vagina! candidiasis, genital shedding of 
cytomegalovirus, cervical dysplasia, and human papilloma virus infection 
with compromised immune systems.
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1993 HIV Prevention Activities: Highlights
Number of HIV Tests at Publicly Funded Sites 
United States, 1985 - 1993
Number of Tests
3,000,000
2,500,000
2,000,000
1,500,000
1,000,000
500,000
0
“*85*
-uiii
85 86 87 88 89 90 91 92 93
Year
Monitored retrospective investigations of patients treated by HIV- 
infected health-care workers. No cases of health-care worker-to-patient 
transmission of HIV were identified among 22,032 patients tested from 
63 health-care practices.
Developed and pilot-tested a 3-day course on HIV prevention counseling.
The counseling approach reflects the style and content in the Technical 
Guidance on HIV Counseling published in the MMWR. The most notable 
changes from prior CDC courses are the concentration on client-centered 
counseling and the establishment of personalized risk-reduction plans. 
Train-the-trainer courses are will be held in 1994 to share the materials with 
instructors from state and large city HIV prevention programs as well as staff 
from the Family Planning Regional Training Centers.
Developed a multisite research design and intervention program to 
prevent HIV-infected men and adolescents, including young men with 
hemophilia, from transmitting Hiv to their sex partners, who could then 
transmit infection to their offspring. These projects share the “Stages of 
Change" model as a common conceptual framework. The facility-based 
activities provide standardized risk-reduction activities and counseling in a 
cohort of HIV-infected men.
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Monitoring the Epidemic •  Published two updates in the MMWR on mortality due to HIV infection among persons
25-44 years of age, focusing on the comparison with other leading causes of death.
Also published an analysis on HIV-related mortality in U.S. cities and states. This study 
reported that HIV infection was the leading cause of death among men 25-44 years of 
age in 64 U.S. cities and among women 25-44 years of age in 9 U.S. cities in 1990, and 
documented the high proportion of deaths due to HIV infection among young men and 
women in several areas.
•  Augmented the ability to type HIV infections and improved our molecular epidemi­
ologic investigations through further enhancements in the application of polymerase 
chain reaction (PCR), direct DNA sequencing, and HIV strain-specific probes to identify 
closely related HIV strains and to establish potential HIV transmission patterns. CDC 
expanded the use of genetic variability analysis and comparison of the evolutionary 
relationships among viral isolates to identify unique genetic variants and to establish 
HIV phylogenetic patterns among study populations. These enhanced proficiencies 
have enabled CDC to successfully investigate a number of HIV transmissions of consid­
erable public health importance in health-care settings and also established the exist­
ence of a new major HIV variant in Romania.
•  Continued to conduct blinded HiV tests on persons examined in the National Health 
and Nutrition Examination Survey ill and released national serostatus estimates based 
on 1988-1991 data.
•  Enrolled more than 600 patients in the Enteric Opportunistic Infections Study, a pro­
spective study designed to follow 1,000 HIV-infected patients in Atlanta, Georgia. 
Patients are being followed monthly for a 1-year period, during which time clinical 
specimens and data related to incidence and risk factors are being collected. The 
study has identified Cryptosporidium infection in 50 (9 percent) HIV-seropositive 
patients. •
•  Awarded funds to 38 state and local health departments to collaborate with other 
health-care providers in conducting TB screening and preventive therapy activities 
among persons at high risk forTB/HIV infection.
1993 HIV Prevention Activities: Other Accomplishments
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1993 HIV Prevention Activities: Other Accomplishments
Monitoring the Epidemic •  Demonstrated that viruses are the most commonly identified causes of gastroenteritis
among HIV-infected patients. Further demonstrated that a newly discovered picorna- 
virus is associated with chronic diarrhea in these patients and that astrovirus is the 
commonly identified cause of acute diarrhea.
•  Continued to conduct, in collaboration with state and local health departments, stan­
dardized HIV seroprevalence surveys in designated subgroups of the U.S. population to 
monitor the HIV epidemic in this country. Results from these studies provide state and 
local health officials with important information needed to develop, target, and evalu­
ate prevention programs; to assess trends in the HIV epidemic and related risk behav­
iors; and to assist in projecting the number of children and adults who will develop 
HIV-associated illness and require medical care.
•  Conduct epidemiologic studies of HIV-infected persons with tuberculosis to document 
clinical characteristics of coinfected persons, describe the epidemiology and natural 
history of HIV and TB in dually infected persons, document the completeness of report­
ing to the AIDS and TB surveillance systems, and evaluate the TB case definition for 
HIV-infected persons.
•  Funded TB-related research activities such as hospital worker skin testing, pilot projects 
for evaluation of surveillance systems, mathematical modeling of TB in the year 2010, 
and an efficacy study of the Bacillus Calmette-Guerin (BCG) vaccine.
•  To improve understanding of the epidemiology of cryptococcal infection, conducted 
active population-based laboratory surveillance and a case-control study of risk factors 
for cryptococcal disease in four U.S. cities. Also developed molecular subtyping tools 
for application in epidemiologic studies of Cryptococcus neoformans infection.
•  Conducted the “Third International Course in Surveillance and Applied Epidemiology for 
HIV and AIDS” in Atlanta, Georgia, for 30 participants from 18 countries.
2 i 1994 Fact Book
Monitoring the Epidemic •  Reported state-specific data on HIV-related knowledge, attitudes, and behavior from
the Behavioral Risk Factor Surveillance System. To assess the extent of community 
awareness and use of HIV prevention services, a series of questions covering these 
topics was included in a population-based chronic disease and health-risk survey in the 
District of Columbia.
1993 HIV Prevention Activities: Other Accomplishments
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Continued support for a multisite study of HIV seroincidence and attitudes toward 
vaccine trials among gay and bisexual men. Recruitment began in Chicago, Denver, 
and San Francisco in January 1993. Of eligible men, 1,487 (86 percent) enrolled in the 
study. Analysis of baseline data indicates that 36 percent of men enrolled are defi­
nitely willing to participate in HIV vaccine trials, 37 percent are probably willing,
20 percent might be willing, and 7 percent are definitely not willing.
% Supported through funding to the United States Conference of Mayors (USCM) five 
grants for collaborative efforts by local health departments and community-based 
organizations to conduct needs assessments to determine local community HIV/AIDS 
prevention needs and capacities. In addition, USCM will provide five grants for imple­
mentation of high priority HIV prevention activities identified during the needs assess­
ments. CDC also provided assistance to USCM to fund an additional 8-10 collaborative 
assessment grants along with 3-4 collaborative implementation grants; the latter will 
focus on high priority needs of gay and bisexual men of color. With CDC support, USCM 
conducted, in five cities, an assessment of the HIV prevention needs of this population 
along with the HIV prevention capacities of their local communities.
% Provided financial and technical assistance for HIV prevention activities to community- 
based organizations (CBOs) serving men who have sex with men, and provided funding 
to national and regional minority organizations (NMOs and RMOs) for support of organi­
zations and agencies that provide HlV/STD prevention services to men who have sex 
with men.
% Completed an ethnographic study of Hispanic/Latino men in southeastern Texas and 
southern California who do not identify themselves as gay but who have sex with 
other men. Men interviewed in public cruising areas, many of whom reported heavy 
drug and alcohol use, had incomplete or superficial knowledge about HIV/AIDS, used 
condoms inconsistently or not at all, and relied on ineffective risk-reduction strategies, 
such as avoiding gay-identified sex partners. A Technical Report of Findings provides 
recommendations for further research and HIV prevention activities for this 
underserved population at risk.
1993 HIV Prevention Activities: Other Accomplishments
Preventing HIV Infection % 
Among Populations at 
Risk: Men Who Have 
Sex With Men
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1993 HIV Prevention Activities: Other Accomplishments
Preventing HIV infection 
Among Populations at 
Risk: Injecting Drug 
Users
•  Collaborated with the National Institute on Drug Abuse (NIDA) and the Center for Sub­
stance Abuse Treatment (CSAT) in issuing an HIV prevention bulletin on bleach disinfec­
tion of drug injection equipment. This bulletin stated that sterile needles and syringes 
are safer than bleach-disinfected, previously used needles and syringes and that, for 
needles and syringes that were going to be re-used, bleach disinfection should reduce 
the risk of HIV transmission. The bulletin provided provisional recommendations for 
multistep procedures for bleach disinfection of needles and syringes, and was widely 
distributed by the CDC, CSAT, and NIDA.
•  In collaboration with the Connecticut Department of Health, completed a 1-year evalu­
ation of the impact of 1992 Connecticut laws that (a) allowed pharmacies to sell up to 
10 needles and syringes without requiring a prescription and (b) decriminalized the 
possession of up to 10 needles and syringes. Studies in pharmacies in Hartford and 
Weathersfield showed a steady increase in purchases of "nonprescription” syringes in 
Hartford. Questionnaire surveys of injecting drug users (iDUs) showed widespread, but 
incomplete knowledge of the new laws; a shift of most frequent source of needles and 
syringes from purchases on the "street” to purchases in pharmacies; and a substantial 
decrease in reported multi-person use (sharing) of injection equipment.
•  Collaborated with the National Academy of Sciences in briefings for the panel on 
needle exchange and bleach distribution programs.
•  With NIDA and CSAT, co-sponsored a workshop on the disinfection of drug injection 
equipment. The workshop participants included staff from the three Federal cospon­
sors and selected representatives from state, public health and drug abuse agencies 
and community-based organizations (CBOs).
•  Provided financial and technical assistance for HIV prevention programs to CBOs 
serving IDUs.
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1993 HIV Prevention Activities: Other Accomplishments
Preventing HIV Infection 
Among Populations at 
Risk: Racial and Ethnic 
Minorities
•  Provided technical assistance to the National Medical Association’s Healthy People 2000 
Project for its targeted media campaign to present important health messages to 
people of color. Through this collaboration, HIV/AIDS prevention billboards were devel­
oped and posted in fourteen major U.S. cities.
•  Provided technical assistance to 10 historically black colleges and universities in Geor­
gia to develop media campaigns for HIV/AIDS prevention. These institutions are work­
ing w ith local health departments, health clinics, public hospitals, college organizations, 
and college and local media to target HIV prevention messages.
•  Continued funding of ARC, which has expanded its Crosslinks satellite program that 
provides to communities and ARC chapters innovative approaches for using its core, 
Hispanic, African-American, and workplace HIV education programs. Black Entertain­
ment Television hosted an ARC Crosslink program on how African-American religious 
institutions can use these HIV education programs. In addition, ARC has collaborated 
with the Boys and Girls Clubs, Inc., to develop an age-appropriate K-12 Afterschool Care 
Curriculum for use in numerous communities across the country, and the Atlanta ARC 
chapter received a grant to provide HIV/AIDS education to nine cluster communities of 
the Atlanta Project spearheaded by former President Jimmy Carter and the Carter 
Center.
•  As part of the HIV Behavioral Research and Evaluation Programs Targeting Communities 
of Color (BREPTCC), initiated two new research projects to examine behavioral issues 
associated with HIV transmission in communities of color. Such pilot studies are useful 
in generating hypotheses or conducting initial evaluations to assist in developing 
directions for future, longer-term, conclusive studies for HIV and STD prevention. CDC 
also continued funding of three existing BREPTCC projects: Alternatives to Prostitution 
Risk Reduction Study; Women and HIV/AIDS Prevention Project: Unintended Effects; and 
Availability and Utilization of Early Intervention Services for Selected Seropositive Popu­
lations. CDC provides technical support through cooperative agreements or contracts, 
or both, to investigators, communities, or institutions who conduct these BREPTCC 
research studies.
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1993 HIV Prevention Activities: Other Accomplishments
Preventing HIV Infection 
Among Populations at 
Risk: Racial and Ethnic 
Minorities
% Funded a 2-year project for HIV prevention among minority populations titled “Cogni­
tive and Institutional Barriers to HIV Prevention Among African Americans.”
% Provided financial and technical assistance to CBOs serving minority and high-risk 
populations in the metropolitan statistical areas most heavily affected by HIV infection 
and AIDS. In addition, CDC funded NMOs and RMOs to support them in assisting organi­
zations and agencies that provide HIV/STD prevention services to racial/ethnic minority 
populations, assess the HIV/STD prevention needs of racial/ethnic minority populations, 
and implement programs to change community norms related to safer behaviors.
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1993 HIV Prevention Activities: Other Accomplishments
Preventing HIV Infection 
Among Populations at 
Risk: Youth
•  Collaborated with the Education Development Center to establish 58 School Health 
Education Training Centers in state and territorial education agencies funded by CDC. in 
1993, these Centers provided training in development, implementation, and evaluation 
of HIV prevention programs to more than 15,000 teachers and other school staff.
•  Convened an expert panel to review scientific literature in order to (1) draw conclu­
sions about the effectiveness of sex and HfV education programs in terms of impact 
on adolescent sexual behavior, (2) determine key elements of effective programs, and 
(3) identify the gaps in knowledge in this area. The literature indicates that such pro­
grams do not hasten the onset of sexual activity or increase sexual frequency. In some 
cases, delay in sexual intercourse was observed as well as an increase in condom use. 
Effective programs were based on social learning theory, focused on specific risk 
behaviors, provided personalized risk information, addressed social and media influ­
ences on adolescents, reinforced positive peer norms, and provided communication 
skills training.
•  Funded a 2-year project for HIV prevention among youth populations, “Familial Influ­
ences on HIV Risk and Risk Reduction Behavior in Adolescents.”
•  Provided financial and technical assistance to CBOs serving youth in high-risk situations.
•  Continued funding of the AIDS Evaluation of Street Outreach Projects (AESOP), an eight- 
site project designed to evaluate the impact of street outreach programs on risk 
behavior of high-risk populations and to develop improvements that can be adapted 
to other programs. The target groups in three of the eight sites are youth in high-risk 
situations (YHRS) (i.e., youth ages 12-23 years who are homeless or runaways, or who 
support themselves through the street economy of drugs, prostitution, panhandling, 
and crime). (See also “Evaluating HIV Prevention Efforts.”)
•  Provided financial and technical assistance to 25 national education and health organi­
zations to help them plan, develop, and disseminate recommendations on HIV educa­
tion for youth in schools and other settings. In addition, CDC provided financial and 
technical assistance to every state, 6 territorial, and 19 local education agencies to 
implement locally determined HIV prevention programs.
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1993 HIV Prevention Activities: Other Accomplishments
Preventing HIV Infection 
Among Populations at
Risk: Women
•  Continued the HIV Epidemiology Research Study (HERS), a collaborative effort between CDC 
and NIH to define, characterize, and determine risk factors for both AlDS-defining and non- 
AlDS-defming illnesses in women. Enrollment of the study cohort began in April 1993. As 
of late 1993, 635 women, including 377 HIV-positive and 258 HIV-negative women, have 
been enrolled. CDC continues to investigate gynecologic conditions associated with HIV 
infection, such as vaginal candidiasis and cervical dysplasia, in smaller cohorts of women.
•  Continued behavioral research under the Comprehensive AIDS and Reproductive Health 
Education Study (Project CARES) to develop, implement, and evaluate interventions for the 
prevention of HIV infection and AIDS in women and infants. Activities include (1) analysis 
of clinic-based strategies to identify and remove barriers to effective use of contraception 
among women at high risk for HIV infection or HIV-infected, (2) assessment of 300 women 
at high risk of HIV infection to determine their readiness for behavior change according 
to the Transtheoretical Stages of Change model, and (3) production and piloting of the 
Project CARES Advocates' Guide to Stages of Change Counseling. As of September 1993,
445 women were enrolled in Project CARES. Multiple process evaluation measures have 
been developed to monitor study implementation at all sites.
•  Developed a multisite research design and intervention program for the Prevention of HIV 
in Women and Infants Demonstration Projects, evaluating HIV prevention services in facili­
ties and at the community level. The projects compare standard family planning services 
with an enhanced reproductive health counseling service that addresses both disease 
prevention and pregnancy planning in a cohort of high-risk and HIV-infected women. 
Barriers to care will be reduced through outreach and provision of services in nontradi­
tional settings, such as drug treatment centers and homeless shelters. Community-level 
interventions (CLls) utilize lay community members and outreach staff to influence the 
behaviors and norms of target populations. CLls include (1) stage-tailored print materials 
that promote the use of condoms for disease and pregnancy prevention, (2) networks of 
peer volunteers who distribute these HIV prevention messages and materials and provide 
social reinforcement for changes in behaviors which reduce the risk of transmission,
(3) outreach staff who tailor their encounters to each woman’s needs as indicated by her 
readiness to adopt safer behaviors, and (4) a Community Mobilization Framework to maxi­
mize community-level participation and diffusion of messages.
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•  Collaborated with the Office of Population Affairs (OPA) to develop a national strategy 
for preventing HIV infection among women attending family planning clinics. This 
national strategy will integrate behavioral research, operations research, and training 
activities to create a combined, multidisciplinary approach for the reduction of HIV 
infection and AIDS among women. The combined efforts of this project will increase 
provider and clinic capacity to promote effective HIV risk-reduction behaviors. As part 
of this collaborative effort, CDC and OPA have jointly convened a Family Planning Train­
ing Partnership for HIV Prevention Work Group to provide an ongoing forum for partici­
pants in the family planning community to discuss the implications of HIV prevention 
research findings for family planning and reproductive health service provision and 
training. In addition, CDC and OPA are examining ways in which HIV education, coun­
seling, and testing (ECT) services are provided in family planning clinics and the effect of 
HIV service integration on the delivery of family planning services from the point of 
view of providers, clinic managers and family planning clients. This study will also 
examine clinic protocols, policies, and systems as well as the impact of HIV service 
integration on clinic efficiency.
•  Provided financial and technical assistance to CBOs serving women, including women of 
color, and provided funding to NMOs and RMOs for support of organizations and agen­
cies that provide HIV/STD prevention services to women.
•  In collaboration with investigators at the Dekalb County Sexually Transmitted Diseases 
Clinic, began planning a study of vulvovaginal candidiasis in HIV-infected women. The 
goals of this study are to understand the natural history of the disease in HIV-infected 
women compared with non-HIV-infected women-, to better define risk factors for 
infection in this high-risk group; to evaluate newer diagnostic methods-, and, by appli­
cation of new molecular typing and antifungal drug susceptibility test methods, to 
determine whether HIV-infected women are more likely to develop “hypervirulent” 
and/or antifungal drug-resistant strains of candidiasis.
1993 HIV Prevention Activities: Other Accomplishments
Preventing HIV Infection 
Among Populations at 
Risk: Women
•  Continued funding of the Pelvic inflammatory Disease in HIV-Infected Women study to 
evaluate the etiology and clinical course of pelvic inflammatory disease in women with 
and w ithout HIV infection. To date, protocols and questionnaires for collecting histori­
cal, clinical, and laboratory data have been finalized.
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1993 HIV Prevention Activities: Other Accomplishments
Preventing HIV Infection % Issued guidelines to prevent patient-to-patient transmission of bloodborne pathogens
in Occupational Settings when administering injections.
•  Sponsored a workshop on engineering controls for preventing airborne infections 
among workers in heaith-care and related facilities. Participants included engineers, 
architects, epidemiologists, health-care workers, hospital representatives, and infec­
tious disease specialists. The conference focused on airborne disease transmission, 
control technologies, and research goals.
% Completed an evaluation of needle-stick injuries among health-care workers in a rural 
hospital. As in large urban hospitals, the lack of time to use universal precautions and 
concerns about interference with skillful performance were the two most frequent 
reasons for noncompiiance in this small rural hospital. Like urban workers, rural work­
ers did not report to their employee health clinics all their exposures to blood or body 
fluids; however, whereas urban workers most frequently cited lack of time as reason 
for not reporting, for rural workers the most common reason was the perception that 
the patient was not infectious.
% Completed studies to assess risk of and develop prevention strategies for occupational 
exposure to blood aerosols-, a final report will be issued in 1994. A report will also be 
issued on completed studies of design factors for sharps disposal containers.
% Continued studies of needle-stick injuries and related behavioral factors, and evalua­
tions of health-care devices intended to reduce the risk of accidental needle sticks to 
heaith-care workers.
% Continued field investigations of risk factors for and control measures to prevent occu­
pational infection with tuberculosis. These investigations have been conducted in 
hospitals, correctional facilities, and a variety of public service offices. Both HIV-positive 
workers and workers with normal immune function are employed in some of these 
organizations, and recommendations will contribute to the protection of all workers 
on site.
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1993 HIV Prevention Activities: Other Accomplishments
Preventing HIV infection 
in Occupational Settings
•  Conducted eight sessions nationwide to train graduate medical faculty in preventing 
occupational transmission of bloodborne diseases (including HIV and hepatitis) and 
tuberculosis. Faculty from 108 residency programs in family medicine, internal medi­
cine, and obstetrics/gynecology attended and will use the information to train resi­
dents in their programs.
•  Published an update of Recommended Infection-Control Practices for Dentistry. 
Although the basic principles of infection control remain unchanged, the emergence 
of new technologies, materials, equipment, and data require continual evaluation of 
current practices. More than 16,000 copies of the new document have been distrib­
uted to interested persons since the update.
•  Revised and published educational materials for dental health-care workers, consistent 
with the 1993 recommendations for infection control in dentistry. Since publication of 
the document, Dental Infection Control File-1993, numerous copies have been distrib­
uted to program directors of dental education institutions, state dental program direc­
tors, dental organizations, and others with interest in dental infection control.
•  Completed the data collection phase of an observational study to determine the 
frequency and nature of percutaneous injuries during the provision of clinical dental 
services.
•  Evaluated toxicity and use of antiretroviral agents for post-exposure prophylaxis as part 
of an ongoing study of health-care workers exposed to HIV-infected blood.
•  Cosponsored a scientific meeting with the American College of Surgeons on preventing 
transmission of bloodborne pathogens in surgical and obstetrics practices.
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•  Completed a 2-year cohort study of young male military conscripts in northern Thai­
land. This study identified sex with female prostitutes as the predominant risk behav­
ior for HIV infection among young Thai men and noted the importance of other STDs as 
cofactors. The higher rate of HIV infection among men from the upper north subregion 
(14 percent) compared with men from other areas (2 percent) is associated with earlier 
onset and greater frequency of sex with prostitutes and less consistent condom use.
•  Continued collaborative agreements with the U.S. Agency for International Develop­
ment (USAID) for the Contraceptive Research and Development (CONRAD) project, which 
is designed to (1) identify characteristics associated with sexual transmission of HIV 
among a cohort of HIV-infected male blood donors and their sex partners, (2) identify 
characteristics of women infected through sexual contact with an HIV-infected partner, 
and (3) identify characteristics of infected male blood donors that are associated with 
greater infectivity to their female partners. The project will also attempt to clarify the 
transmission dynamics of heterosexual transmission of HIV by comparing the risk of 
transmission at different times after infection and different stages of HIV immunosup­
pression. During 1993, data collection instruments were developed and pretested. By 
Summer 1993, 487 potential participants had been screened and 148 couples enrolled.
•  Analyzed data collected from Peace Corps volunteers, returned and current, which 
indicate that volunteers are at a high risk for HIV infection through unprotected sex 
with one or more partners, particularly in countries where infection is widespread. 
STD/Hiv prevention activities must focus on barriers to condom use, including low 
perceived risk for HIV, lack of confidence in condom quality, and perceived resistance 
on the part of a partner to use of condoms.
•  Provided on-site training and continuing technical assistance to community-based 
groups in the Republic of South Africa that are attempting to design STD/HIV preven­
tion activities for black African youth. Qualitative research data, presented at the 8th 
international Conference on AIDS in Africa, indicate that South African township youth 
are in urgent need of community-based interventions that focus on recognizing STD 
symptoms and seeking treatment, sexual negotiation skills, and acceptance of 
condoms.
1993 HIV Prevention Activities: Other Accomplishments
Working With 
International Partners 
Prevent HIV Infection
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1993 HIV Prevention Activities: Other Accomplishments
Working With 
International Partners to 
Prevent HIV Infection
Provided (1) short-term technical assistance to World Bank missions in Brazil, India, 
Uganda, Indonesia, Kenya-, (2) consultants for the World Health Organization’s Global 
Programme on AIDS; and (3) technical assistance for USAID projects in Bolivia, Central 
African Republic, the Caribbean Epidemiology Centre (CAREC), El Salvador, Ghana, Guate­
mala, Honduras, Indonesia, Jamaica, Kenya, Nicaragua, Rwanda, Republic of South 
Africa, Thailand, and Uganda.
•  Provided CDC staff to serve in key United Nations and USAID positions, including posi­
tions as long-term HIV prevention advisors in foreign nations.
•  Provided developmental assistance to AIDS Information Centre (counseling and testing 
network) in Uganda to address specific needs of women, including STD issues, at both 
the community and service delivery levels. In addition, CDC utilized a training manager 
from Uganda’s AIDS information Centre as a consultant on an expert panel to revise U.S. 
guidelines for HIV counseling and testing.
•  Provided international access to National AIDS Clearinghouse and assisted USAID, CAREC, 
Latin American countries, and the Republic of South Africa with specific Clearinghouse- 
related activities.
•  Conducted three HIV prevention education workshops in the Republic of South Africa 
for teachers, social workers, and administrators of private and independent schools as 
well as staff of CBOs serving youth.
•  Completed an evaluation in Uganda of the behavioral impact of HIV counseling and 
testing. Results indicate different types of risk-reduction patterns, according to sero­
type status, suggesting the role of testing components in influencing risk reduction. 
Risk-reduction patterns also varied according to gender and age. Significant risk reduc­
tion was documented among seronegative persons. In addition, CDC initiated an evalu­
ation of a Ugandan medical and social support "club" associated with a counseling and 
testing network. Outcomes to be assessed include behavior change and dissemination 
of HIV prevention into the community. This is relevant to domestic considerations of 
“enhanced counseling and testing” models.
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1993 HIV Prevention Activities: Other Accomplishments
Working With 
International Partners to
Prevent HIV Infection
•  Continued development of decentralized STD services in the Central African Republic, 
which include research related to client demand and service quality.
•  Conducted an “Epidemiology and AIDS" course for more than 20 physicians from Cote 
d’Ivoire and other countries, and conducted a workshop on "Development of an 
Epidemiologic Protocol” for Projet RETRO-C! (Cote d'Ivoire) staff.
•  Cosponsored an HIV/A1DS surveillance workshop for district health officers from Nigeria.
•  Conducted epidemiologic research in Cote d’Ivoire, focusing on HIV-1 and HIV-2, 
perinatal transmission, natural history, HIV and TB, the AIDS case definition, and diag­
nostic laboratory testing.
•  Through the MPEP and in collaboration with the Pan American Health Organization 
(PAHO), assessed the performance of HlV-antibody testing in the National Reference 
Laboratories located in Latin American countries, and provided specialized reports and 
assistance in developing quality assurance programs. In addition, CDC provided perfor­
mance evaluations of plasma donor material for HIV-antibody testing to 120 laborato­
ries in 59 foreign countries.
•  Provided technical assistance to HIV workplace education and business coalition efforts 
in Botswana, Thailand, and Japan.
•  Assisted the Federation of Red Cross and Red Crescent Societies in developing Guide­
lines on Blood Donor Counseling for HIV, for distribution throughout the developing 
world.
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1993 HIV Prevention Activities: Other Accomplishments
Evaluating HIV 
Prevention Efforts
As part of CDC’s ongoing assessment of publicly funded HIV counseling and testing 
services, conducted a study of behavioral and clinical factors related to clients seeking 
services in 25 STD clinics in Illinois. Findings indicated that clients who perceived them­
selves to be at risk for having HIV infection were more likely to initiate and complete all 
stages of the HIV counseling and testing process than were clients who had an actual 
risk for HIV, that is, those who had a history of risk behavior or had a current STD diag­
nosis. However, those who had an actual risk were more likely to test positive for HIV 
infection. This implies that HIV prevention programs should use actual risk rather than 
perceived risk to assess true client risk for HIV infection.
•  Conducted evaluations of the behavioral impact of HIV counseling and testing on more 
than 1,000 clients from methadone clinics in Connecticut and Massachusetts. Of the 
674 clients who recently enrolled in the methadone programs, those reporting 
seropositive test results were more likely to be black and 35 years or older; they were 
also more likely, in the past 30 days, to have injected heroin, injected cocaine, shared 
“works” with strangers, and practiced safer sex. An analysis of the impact of HIV CT on 
behavior change is in progress.
•  Analyzed findings from data on the AIDS Community Demonstration Projects. Findings 
indicate that 1-2 years are required to reach optimal capacity for diffusing prevention 
messages in “hard-to-reach” communities in which individuals are at high risk for HIV 
infection. These messages are best disseminated by the community members them­
selves, and, once the messages saturate the community, significant changes occurred 
in most populations regarding intentions to initiate as well as actual adoption of behav­
ior change.
•  As part of the HIV BREPTCC, initiated two new research projects to examine behavioral 
issues associated with HIV transmission in communities of color. Such pilot studies are 
useful in generating hypotheses or conducting initial evaluations to assist in developing 
directions for future, longer-term, conclusive studies for HIV and STD prevention. (See 
page 25 for more information on BREPTCC studies.)
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1993 HIV Prevention Activities: Other Accomplishments
Evaluating HIV 
Prevention Efforts
•  Continued funding of AESOP, an eight-site project designed to evaluate the impact of 
street outreach programs on risk behavior of high-risk populations and to develop 
improvements that can be adapted to other programs. The eight projects are located in 
6 cities: New York, Philadelphia, Atlanta, Chicago, San Francisco, and Los Angeles. The 
target groups in five of the eight sites are injecting drug users (IDUs); in the three other 
sites, efforts are directed to youth in high-risk situations (YHRS) (i.e., youth ages 12-23 
years who are homeless or runaways, or who support themselves through the street 
economy of drugs, prostitution, panhandling, and crime). Results from the initial round 
of quantitative surveys conducted in 1993 during the second phase of AESOP indicate 
that many of the IDUs and YHRS interviewed had received condoms and other materi­
als from street outreach workers. Each of the eight sites has developed enhancements 
to existing street outreach which are being evaluated through a series of behavioral 
surveys.
•  Provided materials, training, and direct consultation to enable state and local education 
agencies to evaluate their school-based HIV prevention programs. CDC’s Handbook for 
Evaluating HIV Education provided state and local education agency staff with mea­
surement tools and guidelines for conducting evaluations of HIV-related policies, 
teacher training, curricula, and student outcomes.
•  Provided technical assistance to the Colorado State Education Agency to evaluate the 
effectiveness of a classroom-based HIV prevention curriculum. Schools offering the 
special curriculum, which consisted of 15 hours of skills-based activities such as role­
playing, direct instruction on HIV prevention strategies, and peer education, were 
compared with schools offering no structured HIV curriculum. Student assessments 
showed greater knowledge about HIV, greater intent to engage in safer sexual prac­
tices, and actual changes to safer sexual practices among sexually active students at 
a 6-month follow-up.
•  Initiated evaluation of family planning clinics providing HIV ECT services for women and 
continued with a pilot study to evaluate HIV ECT services in clinics serving women.
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1993 HIV Prevention Activities: Other Accomplishments
Evaluating HIV 
Prevention Efforts
•  Awarded a cooperative agreement to Emory University School of Public Health to 
conduct a formative evaluation of developing and existing H1V/AIDS education and 
prevention programs in correctional facilities.
•  Initiated a Mode of Transmission Validation (MTV) Project/Heterosexual Transmission 
Study to examine the usefulness of HIV infection reporting systems (named, anony­
mous, and other alternatives) in epidemiologic monitoring and what is their impact on 
programs providing HIV-related prevention, medical, and social services.
•  Continued evaluation of CDC NAH to determine who is using the Hotline, what topics 
they are discussing, whether there are shifts in caller demographics and issues of 
concern over time, and what impact selected programs, PSAs, and AIDS-related “special 
events" directed at the general public and specific target audiences have on these 
demographics and concerns.
•  Developed and implemented an effectiveness evaluation plan for the ARC “AIDS in the 
Workplace" training program to assess whether the ARC is meeting its learning objec­
tives in each of the five modules of the “AIDS in the Workplace” program, including 
whether or not participants in the “AIDS in the Workplace” program are experiencing 
any measures of behavior change or behavior change intent as a result of participating 
in the program.
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1993 HIV Prevention Activities: Other Accomplishments
Improving Public
Understanding of the 
Epidemic
•  Provided technical assistance for a 120-minute entertainment/education special on 
HIV/AIDS, "In a New Light '93," developed and aired by ABC television. CDC also coordi­
nated public information services through its CDC National AIDS Hotline (NAH) to answer 
viewers’ calls about HIV infection and AIDS, and helped in efforts to extend coverage of 
the special as a news event, resulting in more than 700 print stories in U.S. newspapers 
and magazines.
•  Expanded the capacity of the CDC NAH to allow an average of 5,100 telephone calls per 
day to be answered by NAH information specialists. NAH answered 1.6 million calls in 
1993, the highest number of calls answered in any year since the Hotline began opera­
tion. The Hotline has answered more than 9 million calls since services began. In 
addition, CDC initiated through the NAH a pilot program, “Classroom Calls,” in which 
teachers arrange for their class, using a speaker-phone, to ask HIV/AIDS-related ques­
tions of and receive answers from a Hotline Information Specialist.
•  Implemented an NAH information update system to share "training bulletins" (informa­
tion updates about HIV/AIDS treatment, prevention, or events) with more than 300 
AIDS hotlines, helplines, and service professionals throughout the United States and 
other countries. This system is designed to provide consistent messages from national, 
state, and local hotlines.
•  Convened a “User Needs Assessment” meeting to provide feedback on the current 
information needs of persons using the CDC National AIDS Clearinghouse (NAC) and to 
assess the NAC’s ability to meet those needs. NAC is exploring alternate strategies for 
providing more targeted and explicit materials for at-risk populations. NAC received 
257,574 requests for materials in 1993 and distributed 4.5 million publications.
•  Provided technical assistance for the Surgeon General's Report to the American Public 
on HIV infection and AIDS. The report was released to the public at the ixth Interna­
tional AIDS Conference in Berlin.
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1993 HIV Prevention Activities: Other Accomplishments
Improving Public 
Understanding of the 
Epidemic
•  Conducted Regional Corporate Briefings on BRTA initiative for business leaders in Little 
Rock, Arkansas-, Newark, New Jersey; Chicago, Illinois; Nashville, Tennessee; Orlando, 
Florida; Boston, Massachusetts; and Washington, D.C. Participants indicated that the 
greatest barriers to implementing an HIV/AIDS prevention education program were a 
company’s lack of awareness about the need to respond to HIV/AIDS, competing 
business priorities, and cost. Veiy few reported fear or stigma as a barrier.
•  Continued BRTA outreach activities to business through (1) development of print ads 
and matte service articles that were mailed to 6,275 business/trade publications, 
general publications, newspapers, newsletter, and airline magazines; (2) development 
of airport dioramas that have been placed in multiple sites at 14 airports throughout 
the country-, and (3) responding to business inquiries to the BRTA Resource Service, 
including 8,356 calls from business, labor unions, government agencies, and others.
•  Funded the AIDS National Interfaith Network to provide technical assistance to their 
affiliates for HIV prevention. The cooperative agreement with the University of Texas 
Educational Training center was continued to develop model collaborations among 
public health, community-based organizations, and the religious community.
•  Continued funding of the National AIDS Exhibit Consortium for traveling AIDS exhibits to 
be used in science museums throughout the nation. The exhibits were released in 
November 1993, with 2 years of scheduled exhibitions. The demand has exceeded 
expectations, however, and many communities are now on a waiting list to receive 
the exhibits.
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1993 HIV Prevention Activities: Other Accomplishments
Building HIV Prevention 
Capacity Through 
Laboratory Activities
and Research
•  in collaboration with the Grady Hospital Laboratory in Atlanta, Georgia, evaluated four 
alternative CD4 technologies for precision and accuracy in HIV-infected and uninfected 
persons. These new technologies could potentially replace flow cytometry for the 
evaluation of HIV-infected persons.
•  Assessed the performance of laboratories that test for HIV antibody through MPEP. 
During 1993, MPEP provided performance evaluation sample panels consisting of HIV- 
antibody positive and antibody-negative donor material to more than 1,000 laborato­
ries that are located in the United States and 120 laboratories located in 59 foreign 
countries. Information collected from these laboratories provides CDC with an updated 
data base of testing practices, assists CDC in establishing standards of testing, and 
assists CDC in identifying factors that may affect laboratory testing quality. During 
1993, MPEP also implemented an HlV-antibody testing blind performance evaluation 
study through federally funded counseling and testing sites. This collaboration 
between public health departments, private laboratories, and CDC will result in a better 
understanding of the quality of HlV-antibody testing in the United States.
% Implemented a PCR performance evaluation project for detection of HIV. This pilot 
project will send to 30 laboratories performance evaluation samples for PCR detection 
of HIV-1 in clinical specimens. The project will provide CDC with important information 
about the performance quality of laboratories using PCR.
•  Implemented a Mycobacterium tuberculosis performance evaluation program in 
response to the resurgence of tuberculosis in both the number and types of cases 
reported, and the emergence of new isolates that are drug-resistant. This voluntary 
performance evaluation program will assess the laboratories’ susceptibility testing 
process for multidrug-resistant strains of M. tuberculosis.
•  Mailed a survey to laboratories that perform HlV-antibody testing by enzyme immuno­
assay (EIA) to assess testing practices, potential sources of error, methods of obtaining 
training, and need for training in this type of testing. Information collected in 1993 will 
be used in developing future HIV laboratory training programs.
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1993 HIV Prevention Activities: Other Accomplishments
Building HIV Prevention 
Capacity Through 
Laboratory Activities 
and Research
•  Continued to provide training on HIV laboratory diagnosis and the diagnosis and treat­
ment of opportunistic infections. Through the National Laboratory Training Network 
(NLTN), HIV-related training is provided to state and local public health entities as well as 
private hospitals and providers to ensure that laboratory training and practices remain 
relevant to the changing picture of HIV/A1DS. Almost 4,000 students were enrolled in 
71 training courses, representing both public and private health-care providers. Addi­
tional training courses were provided by CDC, including “Meeting the Challenge: 
Multidrug-Resistant TB" that was duplicated and distributed by the NLTN, resulting in 
19 course presentations in 18 states with 1,001 participants.
% implemented a project to evaluate the impact of CD4 laboratory improvement initiatives. 
This project will include evaluation of courses and materials developed for and pre­
sented by the NLTN, CD4 performance evaluation, and the CDC CD4+ cell testing guide­
lines. in addition, through the Association of Schools of Public Health, MPEP conducted 
blind assessments of CD4 laboratory practices and began conducting on-site evaluations 
of laboratories that perform CD4+ cell testing to determine the standardization of testing 
practices and the performance quality of laboratories performing this test.
% In collaboration with the Association of State and Territorial Public Health Laboratory 
Directors, the Food and Drug Administration (FDA), and NIH, sponsored a CD4 Conference 
in Atlanta, Georgia. Information collected through this conference and the MPEP assisted 
CDC in revising the CD4+ cell testing guidelines, which were published in 1994.
% initiated development of a protocol for a national proficiency testing/accreditation pro­
gram. Such a program will provide important information on the logistic requirements 
for a national CD4 proficiency testing program using whole blood clinical specimens.
% Developed and printed flow cytometric training materials on quality assurance/quality 
control (QA/QQ issues for the CD4+ cell testing laboratory and for the pre- and post­
analytical procedures for CD4+ cell testing. Seven flow cytometric immunophenotyping 
courses were presented by the NLTN with 63 participants receiving hands-on training. 
Additionally, two courses on QA/QC and pre/post-analytical procedures were established 
by the NLTN.
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1993 HIV Prevention Activities: Other Accomplishments
Building HIV Prevention 
Capacity Through 
Laboratory Activities 
and Research
•  Evaluated new and alternate CD4+ cell testing procedures to determine their effective­
ness compared with conventional flow cytometric processes.
•  Implemented a CD4 training needs assessment to collect information through mailed 
surveys, telephone surveys, interviews, and laboratory observations on practices that 
may affect performance in the CD4+ cell testing laboratory. This preliminary informa­
tion has been used to determine needed training support for CD4+ cel! testing labora­
tory personnel.
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Acronyms
AESOP
AHCPR
AIDS
ARC
ARTA
ASTHO
ASTPHLD
AIDS Evaluation of Street Outreach Projects 
Agency for Health Care Policy and Research 
Acquired immunodeficiency syndrome 
American Red Cross 
America Responds to AIDS campaign 
Association of State and Territorial Health Officials 
Association of State and Territorial Public Health
AZT
BCG
BREPTCC
Laboratory Directors 
Zidovudine
Bacillus Calmette-Guerin
HIV Behavioral Research and Evaluation Programs 
Targeting Communities of Color
BRFSS
BRTA
CARES
Behavioral Risk Factor Surveillance System 
Business Responds to AIDS program 
Comprehensive AIDS and Reproductive Health 
Education Study
CBO
CLI
CONRAD
CSAT
CSTE
CTRPN
Community-based organization 
Community-level interventions 
Contraceptive Research and Development project 
Center for Substance Abuse Treatment 
Council of State and Territorial Epidemiologists 
Counseling, testing, referral, and partner 
notification
ECT
EOIS
FDA
HBV
HERS
HE/RR
HIV
HRSA
IDU
IHS
MDRTB
MMW R
Education, counseling, and testing 
Enteric Opportunistic Infections Study 
Food and Drug Administration 
Hepatitis B virus
HIV Epidemiology Research Study 
Health education and risk reduction 
Human immunodeficiency virus 
Health Resources and Services Administration 
Injecting drug user 
Indian Health Service 
Multidrug-resistant tuberculosis 
Morbidity and Mortality Weekly Report
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MPEP Model Performance Evaluation Program
MTV Mode of Transmission Validation project
NAC CDC National AIDS Clearinghouse
NAH CDC National AIDS Hotline
NASTAD National Alliance of State and Territorial AIDS 
Directors
NEP Needle-exchange program
NHANES National Health and Nutrition Examination Survey
NHIS National Health Interview Survey
NIDA National Institute on Drug Abuse
NIH National Institutes of Health
NLTN National Laboratory Training Network
NMO National minority organization
OASH Office of the Assistant Secretary for Health
OPA Office of Population Affairs
OSHA Occupational Safety and Health Administration
PAHO Pan American Health Organization
PCR Polymerase chain reaction
PHS Public Health Service
PMI Prevention Marketing Initiative
PSA Public service announcement
QA/QC Quality assurance/quality control
RMO Regional minority organization
SAMHSA Substance Abuse and Mental Health Services 
Administration
SHAS Supplement to HIV/AIDS Surveillance project
STD Sexually transmitted disease
TB Tuberculosis
TLl T-lymphocyte immunophenotyping
USAID U.S. Agency for International Development
USCM United States Conference of Mayors
WAGS Women’s AIDS Cohort Study
WHO World Health Organization
YHRS Youth in high-risk situations
YRBS Youth Risk Behavior Survey
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